Boehringer Ingelheim’s work to discover and develop innovative new therapeutics will now look to antibodies to attack and treat a wide range of diseases—but there’s a twist.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,